Vulnerability in Bmc Remedy Mid-Tier
CVE-2017-17677
BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.011 (63.2th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 63rd percentile — 63.2% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.011 · newest: 0.011 · change: 0.000
Affected products
- Bmc Remedy Mid-Tier — versions 9.1
Weakness classification (CWE)
References
- af854a3a-2127-422b-91ae-364da2661108 (Product)
- af854a3a-2127-422b-91ae-364da2661108 (Product)
- docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security… (Release Notes, Vendor Advisory)
- seclists.org/fulldisclosure/2017/Oct/52 (Mailing List, Third Party Advisory)
Frequently asked questions
- What is CVE-2017-17677?
- CVE-2017-17677 is a high-severity vulnerability in Bmc Remedy Mid-Tier, classified under Incorrect Permission Assignment for Critical Resource. CVSS score: 8.8/10. Published 2021-05-19.
- How severe is CVE-2017-17677?
- High severity. CVSS v3 base score is 8.8 out of 10.